Today, we’re talking about reimagining access to care — not by building more hospitals, but by redesigning the infrastructure of medicine itself. Hyperbaric oxygen therapy — or HBOT — has been FDA-cleared for decades.

It’s used to treat serious conditions like non-healing diabetic wounds, radiation tissue injury, carbon monoxide poisoning, and osteomyelitis. 

Clinical research shows it can reduce amputation rates, speed up healing, and shorten hospital stays.

But here’s the issue: while nearly one million physician practices operate across the United States, hyperbaric chambers are concentrated in roughly 1,300 facilities — most of them within hospital systems. 

That means for many patients, especially in rural and underserved communities, access isn’t just limited — it’s impractical.

Enter RxAir360 — a U.S.-based medical device company working to bring hospital-grade hyperbaric oxygen therapy directly into physician practice settings through a patented, FDA-pending vertical monoplace chamber engineered specifically for in-office integration.

The company was founded by Morgan State University–trained electrical engineer Diallo “Dee-ah-low” M. Watts, Sr., whose personal journey sparked a decade-long mission to close the access gap in hyperbaric medicine. Joining him is Tony Brown, Chief Marketing Officer and co-owner of American Classic Agency, who brings expertise in commercialization, financial strategy, and scaling sustainable growth models.